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Background: High proportions of human embryos produced by in vitro fertilization are aneuploidy and mosaic.
DNA microarray is one of the most practical screening methods to select euploid embryos for transfer. However,
mosaic pregnancy is still possible due to embryonic mosacism. Here we report a successful pregnancy after transfer
of a mosaic blastocyst with euploid inner cell mass.
Methods: A woman with a previous trisomy 13 pregnancy pursued infertility treatment with preimplantation
genetic screening by a trophectoderm biopsy and DNA microarray. NimbleGen oligonucleotide DNA microarray
was applied to biopsied samples from 13 blastocysts. A euploid blastocyst was transferred to the patient and
subsequent prenatal cytogenetic tests were performed by FISH and/or G banding.
Results: Following DNA microarray, it was found that 5 blastocysts were euploid and 8 were aneuploidy. Transfer
of one euploid blastocyst resulted in a clinical pregnancy. Prenatal cytogenetic tests of samples biopsied from
chorionic villi sample showed both trisomy 21 (47 XX, +21) and euploid (46, XX) cells. Further prenatal cytogenetic
test with a sample from amniotic fluid indicated that all cells were euploid (46, XX). The pregnancy was continued
and a healthy girl was delivered after 41 weeks of gestation.
Conclusions: This is the first report to indicate a mosaic pregnancy after transfer of a “euploid” blastocyst that was
screened by DNA microarray, and the case further confirms that mosaicism is present in human blastocysts
produced by in vitro fertilization.
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Mosaicism refers to the presence of two or more cell lines
in an individual or tissue sample [1]. When mosaicism is
found in cultured fetal cells, there may be problems in
interpreting whether the fetus is truly mosaic and in
determining the clinical significance of this apparent
mosaicism. Mosaicism can be detected from chorionic
villi sample (CVS) or amniotic fluid by cytogenetic
tests, such as fluorescence in-situ hybridization (FISH),
GTG banding and DNA microarray [2-4]. Mosaicism can
either be true mosaicism and false mosaicism. It has been
found that true mosaicism is usually associated with a high
risk of mosaicism present in the fetus [5].
Mosaicism is sometimes present in the placenta but
absent in the fetus and this genetic inconsistency within* Correspondence: wangweihua11@yahoo.com
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reproduction in any medium, provided the orthe conceptus is known as confined placental mosaicism
[5]. It has been reported when a live born infant or fetus
has non-mosaic trisomy 13 or trisomy 18, there is pla-
cental mosaicism with normal cell line and/or a trisomic
cell line [6]. In this case, the percentage of placental cells
with a normal karyotype ranges from 12% to 100% [7-9].
This data suggests that a normal or abnormal placenta
may be able to maintain the pregnancy of a trisomy
fetus. It also suggests that a mosaic placenta can support
a pregnancy of a normal fetus.
Confirmation and interpretation of mosaicism are among
the most difficult challenges in genetic counseling for pre-
natal diagnosis. Currently, accurate prediction of clinical
outcome based on information describing mosaicism may
be impossible. Thus further studies with different tissue
samples (CVS, amniocentesis or cordocentesis) at different
periods of gestation may provide a more complex evalu-
ation [2,3,6-9].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in vitro fertilization (IVF) are not only aneuploidy, but
also mosaic [10-13]. Recently, a normal pregnancy was
established after transfer of a day 5 blastocyst that was
aneuploidy on a day 3 embryo biopsy screened by DNA
microarray [14]. We also found that mosaicism is highly
present in human blastocysts and a high proportion of the
mosaic blastocysts had euploid inner cell mass (ICM),
suggesting that transfer of these embryos may produce
normal babies [13]. This kind of mosaicism, called
diploid-aneuploid mosaicism [15], has been detected in
trisomic and monosomic spontaneous abortion [16]. Pre-
vious study with blastocysts produced by IVF also indi-
cated a high diploid-aneuploid mosaicism although the
study did not compare trophectoderm (TE) and ICM [15].
When we compared ICM and TE samples from IVF blas-
tocysts, we found that most diploid-aneuploid blastocysts
actually had euploid ICM [13]. Therefore, if inconsistent
mosaicism is present in a blastocyst between TE and ICM
or inside TE cells, the information obtained by TE biopsy
may not represent the actual chromosomal information in
the embryo [13]. For example, if a blastocyst has a euploid
ICM but an aneuploid TE or mosaic TE, the test infor-
mation may mislead the decision for the final dispos-
ition of the embryo. If the biopsied cells are aneuploid,
the embryos are considered abnormal and would not be
considered for transfer. Thus, the patients may lose the
chance to become pregnant if all of the viable embryos
demonstrate aneuploidy.
Based on previous studies, TE biopsy and DNA micro-
array can significantly increase chance of embryo implant-
ation [13,17-19], which suggests that DNA microarray of
human blastocysts can screen most of the embryos. How-
ever, it is still difficult to correctly test the embryos because
of mosaicism. Here, we report a case in which microarrayTable 1 Microarray outcome of the biopsied trophectoderm s











11C 091912-25-D6 Multiple chr
12C 091912-26-D6 44,XY,-16,-21
13C 091912-27-D6 44,XY,-8,-9of biopsied TE indicated a euploid embryo, but prenatal
cytogenetic tests indicated a trisomy 21 placenta. Further
testing demonstrated a normal euploid fetus.
Case presentation
A 38 year old woman previously had two IVF cycles and
a total of 5 embryo transfers (two fresh transfers and
three frozen embryo transfers). The patient conceived
following the last transfer, but ultrasonography demon-
strated that the fetus developed abnormally. Cytogenetic
testing showed trisomy 13. After termination of the
pregnancy, the patient decided to have a third IVF cycle
with 23-pair chromosome preimplantation genetic screen-
ing (PGS).
From the third IVF cycle, 25 eggs were retrieved and 22
were mature. After insemination and embryo culture, a
total of 13 blastocysts were produced on Days 5 and 6. All
blastocysts were biopsied for microarray with NimbleGen
oligonucleotide DNA microarray platform [13]. The re-
sults of the PGS are shown in Table 1. Embryo number 7,
a day 5 euploid hatching blastocyst (Figure 1) was trans-
ferred. Vaginal sonography demonstrated normal fetal
growth in the first trimester.
As the patient was of advanced reproductive age, and
because of a previous pregnancy with trisomy 13, the
patient decided to have a prenatal cytogenetic testing.
Prenatal cytogenetic test by 5 probes (13, 18, 21, X and Y)
FISH of biopsied CVS samples showed that all cells (x100)
had trisomy 21. However, GTG banding for chromosome
analysis of cultured another CVS sample was euploid (46,
XX). A microarrray was also performed on both CVS
samples and it was showed a mixture of 46, XX and 47,
XX, +21.
After the CVS results were made available, the DNA
microarray from the trophectoderm biopsy was repeatedamples
Interpretation Final disposition
0 Aneuploidy Still in storage
Aneuploidy Still in storage
Aneuploidy Still in storage
Aneuploidy Still in storage
Euploid Still in storage
Euploid Still in storage
Euploid Transferred
Euploid Still in storage
Euploid Still in storage
Aneuploid Still in storage
omosomal abnormalities Still in storage
Aneuploidy Still in storage








Figure 1 Morphology and PGS chart of a blastocyst transferred. A) Blastocyst after warming and B) same blastocyst after 2 hrs of culture.
C) PGS chart of the sample biopsied from the blastocyst, showing 46, XX. D) Diagram of the blastocyst based on the PGS and prenatal cytogenetic
tests, showing that the blastocyst has euploid inner cell mass, partial euploid trophectoderm (TE) and partial aneuploid (47, XX, +21) TE. Yellow arrows
indicate the inner cell mass (ICM), and red arrows indicate the TE.
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Later at 15 weeks gestation, a sample of amniotic fluid
was collected. FISH showed that all cells (x100) were
46, XX and GTG banding showed all cells (x30) were
46, XX too.
The pregnancy was continued with no sign of develop-
mental abnormality and a healthy girl, weight 6 lbs 14 oz,
was delivered by C section on June 6th, 2013.
Discussion
Mosaic pregnancy has been previously observed in natural
conception by prenatal diagnosis [5-9]. It has been found
that some fetuses had normal chromosomes while the pla-
centa had either normal and abnormal chromosomes, or
completely abnormal chromosomes [5-8]. It is estimated
that approximately 2% of viable pregnancies have this kind
of mosaicism [9]. Furthermore, it is reported that there
was about a 10% of risk of fetal mosaicism when placental
mosaicism was diagnosed [9]. This indicates that most of
the fetuses may be normal even if the placental mosaicism
is found. Prevalence of chromosomal mosaicism in preg-
nancies from infertile couples was similar to those con-
ceived naturally [20].Previous studies by IVF and PGS indicated that mo-
saicism was mainly present in cleavage human embryos
[10-12]. However, we recently found that high propor-
tions of human blastocysts also are mosaic by DNA
microarray of samples biopsied from ICM and two dif-
ferent locations of TE cells [13]. We found that some
aneuploid/mosaic blastocysts screened by microarray
had euploid ICM cells, thus transfer of these embryos
would result in birth of healthy babies. The present case
report, for the first time, provides the evidence that a
healthy baby can be born if a blastocyst had a euploid
ICM and mosaic TE.
Based on our previous findings [13], there are four
different human embryonic mosaicisms: 1) embryos had
aneuploid ICM and had both euploid and aneuploid TE
cells; 2) embryos had aneuploid ICM and had euploid
TE cells. These embryos are considered to be abnormal;
3) embryos had euploid ICM and aneuploidy TE cells
and 4) embryos had euploid ICM and had both euploid
and aneuploidy TE cells. Because these mosaic embryos
have euploid ICM, transfer of these blastocysts should
be able to establish a normal pregnancy. As shown in
Figure 1, current pregnancy was established by transfer
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and aneuploidy TE cells.
Although high frequencies of mosaicism have been
reported in preimplantation human embryos, especially
from women with advanced maternal age [10-12], the
frequency of chromosomal mosaicism in spontaneous
abortion specimens is still low [16]. This indicates that
most of the mosaicism is placental mosaicism or placental
aneuploidy and most mosaic embryos are lost if they have
aneuploid ICM, resulting mainly from the first trimester
spontaneous abortion [16]. It would appear that the rate
of mosaic pregnancy is not related to infertility treatment
and IVF [15]. It has been reported that there was no dif-
ference in the prevalence of mosaicism during the first
trimester of pregnancies conceived naturally or with
IVF [20]. However, it was found that diploid-aneuploid
mosaicism rate is quite high in the blastocysts produced
by IVF [15]. According to our previous study, four out
of nine diploid-aneuploid mosaic blastocysts had euploid
ICM [13]. These embryos are not used for transfer if PGS
shows aneuploidy. Therefore, it was suggested that a sec-
ond TE biopsy and microarray may be necessary if all
embryos are aneuploid in a cohort of embryos from one
IVF cycle and a normal embryo may be found for transfer.
The second biopsy and microarray may be suitable only
for embryos with a single chromosomal abnormality as it
was found that some mosaic embryos with only a single
chromosomal error had euploid ICM and no blastocyst
with multiple chromosomal errors had euploid ICM [13].
Thus, we expect that blastocysts with multiple chromo-
somal errors may have significantly decreased chance of
possessing a euploid ICM. Further studies remain neces-
sary to confirm this hypothesis.
Conclusions
In conclusion, this case report indicates that normal
pregnancy and live birth of a healthy baby are possible if
the diploid-aneuploid human mosaic blastocyst has a eu-
ploid ICM. A second TE biopsy may be necessary to find
normal embryos from a cohort of mosaic blastocysts if
all embryos are aneuploidy. Furthermore, the second TE
biopsy and microarray likely should be limited to the
embryos with a single chromosomal error.
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